BioregulatorResearch
Chonluten
Also known as: Glu-Asp-Gly · EDG
A tripeptide bioregulator for pulmonary repair, targeting damaged bronchial and alveolar tissue.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
Half-Life
~30 minutes
Typical Dose
10 mg daily (oral, cycled)
Administration
Oral capsule
Mechanism of Action
Epigenetic optimization of lung epithelial gene expression for respiratory membrane repair and regeneration.
Key Research Areas
bioregulatorlungsrespiratorypulmonary
Frequently Asked Questions
What is Chonluten?▾
A tripeptide bioregulator for pulmonary repair, targeting damaged bronchial and alveolar tissue.
How does Chonluten work?▾
Epigenetic optimization of lung epithelial gene expression for respiratory membrane repair and regeneration.
What is the recommended dosage for Chonluten?▾
The typical research dosage is 10 mg daily (oral, cycled), administered via Oral capsule. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Chonluten?▾
The half-life of Chonluten is approximately ~30 minutes. This affects dosing frequency and timing in research protocols.
Is Chonluten FDA approved?▾
Chonluten is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.
Research Disclaimer
The information provided about Chonluten is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.